Holen Sie sich die Stockscreener-App
0.8451
1.72%
-0.0148
Handel nachbörslich:
.87
0.0249
+2.95%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SCYX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.8599
Offen:
$0.84
24-Stunden-Volumen:
123.41K
Relative Volume:
0.66
Marktkapitalisierung:
$32.98M
Einnahmen:
$135.87M
Nettoeinkommen (Verlust:
$72.20M
KGV:
0.5951
EPS:
1.42
Netto-Cashflow:
$45.09M
1W Leistung:
+15.45%
1M Leistung:
+20.21%
6M Leistung:
-27.77%
1J Leistung:
-51.15%
1-Tages-Spanne:
$0.825
$0.87
1-Wochen-Bereich:
$0.7499
$0.9212
52-Wochen-Spanne:
$0.66
$1.79
Scynexis Inc Stock (SCYX) Company Profile
Firmenname
Scynexis Inc
Sektor
Telefon
201-884-5485
Adresse
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Vergleichen Sie SCYX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCYX
Scynexis Inc
|
0.8451 | 34.34M | 135.87M | 72.20M | 45.09M | 1.42 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-22 | Eingeleitet | Guggenheim | Buy |
| 2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-11 | Hochstufung | Needham | Hold → Buy |
| 2018-06-27 | Eingeleitet | Maxim Group | Buy |
| 2017-10-24 | Eingeleitet | Guggenheim | Buy |
| 2017-07-10 | Eingeleitet | ROTH Capital | Buy |
| 2017-05-09 | Herabstufung | Needham | Buy → Hold |
| 2017-03-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-10-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-10-07 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2016-10-03 | Fortgesetzt | Brean Capital | Buy |
| 2016-08-17 | Eingeleitet | Guggenheim | Buy |
| 2016-08-09 | Bestätigt | Needham | Buy |
| 2016-08-09 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2016-03-28 | Eingeleitet | Brean Capital | Buy |
| 2015-12-29 | Eingeleitet | WBB Securities | Speculative Buy |
| 2015-11-16 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-06-10 | Eingeleitet | Needham | Buy |
| 2014-05-29 | Eingeleitet | Canaccord Genuity | Buy |
| 2014-05-29 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Scynexis Inc Aktie (SCYX) Neueste Nachrichten
SCYNEXIS Restarts Key Phase 3 Trial but Faces Payment Dispute with Partner GSK over $30M Milestone - Stock Titan
Is SCYNEXIS Inc. stock poised for growthEarnings Miss & Daily Volume Surge Trade Alerts - Newser
SCYNEXIS Inc. stock trend forecastJuly 2025 Institutional & High Win Rate Trade Tips - Newser
Historical volatility pattern of SCYNEXIS Inc. visualizedQuarterly Trade Review & Capital Efficient Trade Techniques - Newser
Price momentum metrics for SCYNEXIS Inc. explainedWeekly Trade Recap & High Return Trade Opportunity Guides - Newser
SCYNEXIS Inc. stock retracement – recovery analysis2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - Newser
How high can SCYNEXIS Inc. stock goRisk Management & Reliable Entry Point Trade Alerts - Newser
What’s next for SCYNEXIS Inc. stock priceEarnings Risk Summary & Daily Technical Forecast Reports - Newser
Can SCYNEXIS Inc. hit a new high this month [Weekly Trading Summary]Weekly Chart Analysis and Trade Guides - Newser
Can SCYNEXIS Inc. hit a new high this monthBuy Opportunity Forecast for Fast Traders - Newser
Using Python tools to backtest SCYNEXIS Inc. strategiesMarket Activity Report & Weekly Chart Analysis and Guides - Newser
Chartists See Breakout Potential in SCYNEXIS Inc.Low Risk Swing Trade Opportunities Identified - 선데이타임즈
Published on: 2025-08-11 23:14:27 - Newser
Technical analysis overview for SCYNEXIS Inc. stockFree Fundamental Winners With Safe Entry Plan - Newser
Reviewing CytoDyn (OTCMKTS:CYDY) & SCYNEXIS (NASDAQ:SCYX) - Defense World
Key metrics from SCYNEXIS Inc.’s quarterly dataAI-Based Signal Detection for Active Traders - Newser
What candlestick patterns are forming on SCYNEXIS Inc.Triple Digit Gain Opportunity Watchlist - Newser
Will a bounce in SCYNEXIS Inc. offer an exitDaily Profit Watch With Forecast Confidence - Newser
Top chart patterns to watch in SCYNEXIS Inc.Secure Asset Flow and Trend Pattern Analysis - Newser
Why SCYNEXIS Inc. stock attracts strong analyst attentionFree Investment Strategy With Low Risk - Newser
SCYNEXIS Inc. Advances Phase 3 Study for Invasive Candidiasis Treatment - MSN
Real time scanner hits for SCYNEXIS Inc. explainedAI-Powered Stock Trend Movement Analysis - Newser
Sector ETF performance correlation with SCYNEXIS Inc.Intraday Price Forecast Using Volume Models - Newser
Applying big data sentiment scoring on SCYNEXIS Inc.Short-Term Upside Breakout Forecast System - Newser
Volatility clustering patterns for SCYNEXIS Inc.AI Short-Term Gain Forecast with Data - Newser
SCYNEXIS (SCYX) to Release Earnings on Thursday - Defense World
SCYNEXIS Inc. Advances Antifungal Treatment with Phase 3 Study - TipRanks
What are the latest earnings results for SCYNEXIS Inc.Build wealth with reliable stock picks - Jammu Links News
SCYNEXIS Inc. Stock Analysis and ForecastExplosive returns - Jammu Links News
What are analysts’ price targets for SCYNEXIS Inc. in the next 12 monthsExceptional growth trajectory - Jammu Links News
Finanzdaten der Scynexis Inc-Aktie (SCYX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):